Original Research
Accepted on 10 Nov 2025
Combining Mechanistic Quantitative Systems Pharmacology Modeling and Patient-Derived Organoid Testing in MET-aberrant Non-Small Cell Lung Cancer for High-throughput Combination Efficacy Analysis and Personalized Treatment Design
in Experimental Pharmacology and Drug Discovery